LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase
· Egyptian market news
LVP Pharma upped its stake in EGX-listed pharma giant Rameda to 31.5%, effectively buying out Equinox Pharma Holdin g in an EGP 847 mn transaction bourse disclosure (pdf)
LVP is now within touching distance of the MTO line.
IN CONTEXT- back in March
Expect more buying ahead:
A new board: non-executive chairman
“Our next big move is regional expansion
Who else sits at the cap table: 1Q shareholding disclosure (pdf)
A snapshot of Rameda’s 2025 earnings: 48% y-o-y
Original source: enterpriseam.com